Related Experiment Video
Updated: May 25, 2026
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Compressed opiate withdrawal syndrome and naltrexone
1The Maudsley Hospital and National Addiction Centre, Camberwell, London SE5 8AF, UK.
Journal of Psychopharmacology (Oxford, England)
|February 3, 2012
Summary
Naltrexone, an oral opiate antagonist, can trigger acute opioid withdrawal in dependent individuals. This study reports two cases, highlighting the compressed withdrawal syndrome and its management implications.
Area of Science:
- Pharmacology
- Addiction Medicine
- Clinical Neuroscience
Background:
- Naltrexone is an oral opiate antagonist used clinically for abstinent opiate-dependent individuals.
- Acute opioid withdrawal is a known risk when naltrexone is taken by opiate-dependent individuals.
Purpose of the Study:
- To report two cases of naltrexone-induced acute opioid withdrawal.
- To discuss the compressed nature of this withdrawal syndrome.
- To explore implications for managing protracted withdrawal symptoms and review theoretical aspects.
Main Methods:
- Case report analysis of two individuals experiencing naltrexone-induced opioid withdrawal.
- Clinical observation and discussion of withdrawal syndrome characteristics.
- Review of theoretical and experimental literature on naltrexone and opioid dependence.
Main Results:
- Two distinct cases of acute opioid withdrawal precipitated by naltrexone administration were documented.
- The withdrawal syndrome presented in a compressed and intense manner in both cases.
- Observed withdrawal patterns suggest potential challenges in managing protracted symptoms.
Conclusions:
- Naltrexone can induce a rapid and intense opioid withdrawal syndrome.
- Understanding this phenomenon is crucial for effective patient management and treatment strategies.
- Further research into the theoretical underpinnings may refine clinical interventions for opioid dependence.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
04:11A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...